We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $111M
1-Year Est. Return 74.4%
This Fund
S&P 500
This Quarter Est. Return
-41%
1 Year Est. Return
-74.4%
3 Year Est. Return
-95.55%
5 Year Est. Return
-99.44%
10 Year Est. Return
-99.5%
AUM
$147M
AUM Growth
-$523M
Cap. Flow
+$29.5M
Cap. Flow %
20.1%
Top 10 Hldgs %
64.77%
Holding
167
New
23
Increased
38
Reduced
54
Closed
36

Top Buys

Rank Stock Value
1
GEVO icon
Gevo
GEVO
+$20.1M
2
DOGZ icon
Dogness International Corp
DOGZ
+$8.37M
3
ONCO icon
Onconetix
ONCO
+$5.5M
4
MMAT
Meta Materials Inc. Common Stock
MMAT
+$3.83M
5
NEPT
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
+$3.81M

Top Sells

Rank Stock Value
1
CNTX icon
Context Therapeutics
CNTX
+$2.53M
2
HMCO
HumanCo Acquisition Corp. Class A Common Stock
HMCO
+$1.42M
3
USWS
U.S. Well Services, Inc. Class A Common Stock
USWS
+$1.07M
4
GYRE icon
Gyre Therapeutics
GYRE
+$871K
5
AGMH icon
AGM Group Holdings
AGMH
+$859K

Sector Composition

Rank Sector Weight
1 Miscellaneous 64.77%
2 Healthcare 12.59%
3 Materials 8.79%
4 Technology 5.45%
5 Consumer Discretionary 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HMCOW
101
DELISTED
HumanCo Acquisition Corp. Warrant
HMCOW
$46K 0.03%
400,314
+200,000
+100% +$53.2K
CAN
102
CALL
Canaan Creative
CAN
$259M
$45K 0.03%
+141
New +$532
MTVA
103
MetaVia Inc
MTVA
$10.7M
$45K 0.03%
35
-106
-75% -$167K
GMBL
104
DELISTED
Esports Entertainment Group Inc. Common Stock
GMBL
$44K 0.03%
+3
New +$62.1K
ORIO
105
PUT
Orion Digital Corp
ORIO
$24.8M
$40K 0.03%
154
-12
-7% -$57
BXRX
106
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$40K 0.03%
1,179
+706
+149% +$33K
CBAT icon
107
PUT
CBAK Energy Technology Ltd
CBAT
$88.6M
$36K 0.02%
339
-2,153
-86% -$2.49K
BJDX icon
108
Bluejay Diagnostics
BJDX
$880K
$35K 0.02%
+1
New +$35.5K
ANY icon
109
CALL
Sphere 3D
ANY
$25.5M
$30K 0.02%
8
+5
+167% +$432
EQOS
110
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$30K 0.02%
36,354
+2,467
+7% +$3.29K
SPI
111
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
$30K 0.02%
17,395
-174,229
-91% -$372K
SPI
112
PUT
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
$30K 0.02%
174
-2,600
-94% -$5.55K
RKDA icon
113
PUT
Arcadia Biosciences
RKDA
$1.04M
$29K 0.02%
7
-7
-50% -$322
BIOC
114
DELISTED
Biocept, Inc.
BIOC
$29K 0.02%
1,017
– –
NCTY
115
The9 Ltd
NCTY
$63.8M
$24K 0.02%
1,445
-6,520
-82% -$129K
PMCB icon
116
CALL
PharmaCyte Biotech
PMCB
$4.21M
$23K 0.02%
+102
New +$223
CBAT icon
117
CBAK Energy Technology Ltd
CBAT
$88.6M
$22K 0.02%
20,298
-179,727
-90% -$208K
SLAI
118
PUT
DELISTED
SOLAI Ltd ADS
SLAI
$21K 0.01%
5
-11
-69% -$1.38K
CORZ
119
CALL
DELISTED
Core Scientific, Inc. Common Stock
CORZ
$18K 0.01%
120
-1,176
-91% -$5.4K
BBLGW
120
Bone Biologics Corp Warrants
BBLGW
$18.3M
$16K 0.01%
3,616
– –
GMBLW
121
CALL
DELISTED
Esports Entertainment Group Inc. Warrant
GMBLW
$11K 0.01%
+263
New +$45
DMK
122
PUT
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$11K 0.01%
+3
New +$94
AGTC
123
CALL
DELISTED
Applied Genetic Technologies Corporation
AGTC
$11K 0.01%
140
– –
EQOS
124
PUT
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$10K 0.01%
125
– –
GMBLW
125
PUT
DELISTED
Esports Entertainment Group Inc. Warrant
GMBLW
$8K 0.01%
200
+100
+100% +$17
3 4
5
6 7

Similar funds

IWA
Independent Wealth Advisors Cary, North Carolina $111M AUM
BFA
Ballast Financial Advisors West Chester, Pennsylvania $110M AUM
WPWM
Western Pacific Wealth Management Lake Forest, Illinois $111M AUM 26.64% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
ZS
Zenith Solutions Philadelphia, Pennsylvania $110M AUM
KC
Karras Company Roy, Utah $110M AUM
FI
FinArc Investments Norwood, Massachusetts $110M AUM
CIM
Catalyst Investment Management Windham, New Hampshire $110M AUM

Sabby Management's Q2 2022 Portfolio in Review

As of Q2 2022, Sabby Management held 167 positions worth $147M, down 78% from $670M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Sabby Management deployed $29.5M of net new capital in Q2 2022, opening 23 new positions and adding to 38 existing holdings. Its largest new stake was Gevo: 5,486,831 shares worth $12.9M.

By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, down from 88% a quarter earlier, followed by Healthcare and Materials.

On the sell side, the largest reduction was HumanCo Acquisition Corp. Class A Common Stock, an estimated $1.42M trimmed.

  • Sabby Management's largest Q2 2022 buy was Gevo: 5,486,831 shares worth $12.9M.
  • Sabby Management added most to Canaan Creative in Q2 2022, an estimated $1.46M increase.
  • Sabby Management's biggest Q2 2022 reduction was HumanCo Acquisition Corp. Class A Common Stock, cutting an estimated $1.42M.
  • Sabby Management fully exited Context Therapeutics in Q2 2022, selling an estimated $2.53M.
  • Sabby Management's ten largest holdings make up 65% of its $147M portfolio in Q2 2022.
  • Sabby Management opened 23 new positions and closed 36 in Q2 2022.
  • Sabby Management's portfolio value fell 78% quarter-over-quarter to $147M.

Based on Sabby Management's 13F filing for Q2 2022, filed 15 Aug 2022.